Controlled Substance API Market - Top Companies and Manufacturers

  • Report ID: 5223
  • Published Date: Aug 02, 2024
  • Report Format: PDF, PPT

Companies Dominating the Controlled Substance API Landscape

    • Pfizer Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Johnson & Johnson
    • Novartis AG
    • Roche Holding AG
    • Teva Pharmaceutical Industries Ltd.
    • GlaxoSmithKline plc
    • Eli Lilly and Company
    • AstraZeneca plc
    • Merck & Co., Inc.
    • AbbVie Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Novartis to lay off 8,000 jobs worldwide. The Swiss pharmaceutical company announced plans to cut 8,000 jobs, or 7% of its workforce, in a bid to save USD 1 billion. The layoffs will affect employees across all levels and functions, and will be implemented over the next two years.
  • Novartis receives positive CHMP opinion for multiple sclerosis biosimilar natalizumab. The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Novartis's biosimilar natalizumab, which is used to treat multiple sclerosis.

Author Credits:  Radhika Pawar


  • Report ID: 5223
  • Published Date: Aug 02, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of controlled substance api is evaluated at USD 11.82 Billion.

The controlled substance api market size was valued at USD 10.92 Billion in 2023 and is anticipated to exceed USD 34.29 Billion by the end of 2036, registering over 9.2% CAGR during the forecast period i.e., between 2024-2036. Increasing investment in pharmaceutical infrastructure is the major factor driving the market growth.

North America industry is poised to hold the second-largest share by 2036, due to high burden of chronic diseases, including cardiovascular diseases, diabetes, and neurological disorders in the region.

Pfizer Inc., Johnson & Johnson, Novartis AG, Roche Holding AG, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Eli Lilly and Company, AstraZeneca plc, Merck & Co., Inc., AbbVie Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample